SCHEMBL1711927

SCHEMBL1711927

C=C(C)C(=O)NOB(O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 1/20 0.45
TDP1 Q9NUW8 1/20 0.35
ELANE P08246 1/20 0.34
GAA P10253 2/20 0.34
POLB P06746 2/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
ENPP2 Q13822 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
PCSK9 Q8NBP7 1/20 0.33
ORAI1 Q96D31 1/20 0.33
ORAI2 Q96SN7 1/20 0.33
ORAI3 Q9BRQ5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylamide SCHEMBL23531961 0.91 ALDH1A1 (0.39) ALDH1A1KDM4ETDP1ELANEGAA
SCHEMBL910653 0.82 NAPRT (0.41) ALDH1A1GAAPOLBL3MBTL1CA4
SCHEMBL1370188 0.82 MAPT (0.36) ALDH1A1KDM4ETDP1GAATSHR
SCHEMBL27175900 0.78 ALDH1A1 (0.42) ALDH1A1KDM4ETDP1ELANEGAA
SCHEMBL56442 0.77 ORAI1 (0.39) ALDH1A1TDP1GAAPOLBRECQL
SCHEMBL7040701 0.76 ALDH1A1 (0.41) ALDH1A1KDM4EGAARECQLCA4
SCHEMBL1711735 0.75 TGM2 (0.46) ALDH1A1CA4CA6CA5ACA7
SCHEMBL28524847 0.74 ELANE (0.44) ALDH1A1KDM4ETDP1ELANEPOLB
SCHEMBL20483698 0.74 ALDH1A1 (0.52) ALDH1A1GAAPOLBHSD17B10MAPT
SCHEMBL1723147 0.74 ALDH1A1 (0.49) ALDH1A1KDM4ETDP1ELANEGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076533-A1 SYNTHESIS OF LACTONE DERIVATIVES AND THEIR USE IN THE MODIFICATION OF PROTEINS GENIE BIOTECH UK LTD. (GB) 2022-10-26 EP claimed
CN-114085391-B High-sensitivity flexible pressure sensing material in pure water and application thereof 天津大学 2022-05-13 CN claimed
CN-114085391-A High-sensitivity flexible pressure sensing material in pure water and application thereof 天津大学 2022-02-25 CN claimed
US-10792620-B2 Grafted ultra high molecular weight polyethylene microporous membranes ENTEGRIS, INC. (US) 2020-10-06 US claimed
EP-3390715-A1 BORONIC ACID CONTAINING POLYMERS FOR PAPERMAKING PROCESS Ecolab USA Inc. (US) 2018-10-24 EP claimed
WO-2017106310-A1 BORONIC ACID CONTAINING POLYMERS FOR PAPERMAKING PROCESS ECOLAB USA INC. (US) 2017-06-22 WO claimed
US-7988988-B2 Contact lenses with mucin affinity BAUSCH & LOMB INCORPORATED (US) 2011-08-02 US claimed
EP-2344885-A2 MATERIALS AND METHODS FOR RESOLVING POLYHYDRIC SPECIES BY ELECTROPHORESIS The University of Bath (GB) 2011-07-20 EP claimed
US-7832856-B2 lens is coated with first polymer, such as a boronic acid-containing copolymer, having affinity to mucin, and second polymer which improves initial comfort of contact lens; during wear of lens, second polymer is removed from lens by blinking or tear fluids, and mucin complexes with first polymer BAUSCH & LOMB INCORPORATED (US) 2010-11-16 US claimed
WO-2010041037-A2 MATERIALS AND METHODS FOR RESOLVING POLYHYDRIC SPECIES BY ELECTROPHORESIS THE UNIVERSITY OF BATH (GB) 2010-04-15 WO claimed
EP-1968658-A2 CONTACT LENSES WITH MUCIN AFFINITY BAUSCH & LOMB INCORPORATED (US) 2008-09-17 EP claimed
WO-2008079495-A2 COATINGS AND SOLUTIONS FOR CONTACT LENSES BAUSCH & LOMB INCORPORATED (US) 2008-07-03 WO claimed
US-20080151181-A1 Coatings and Solutions for Contact Lenses BAUSCH & LOMB INCORPORATED (US) 2008-06-26 US claimed
US-20080151180-A1 Coatings and Solutions for Contact Lenses BAUSCH & LOMB INCORPORATED (US) 2008-06-26 US claimed
WO-2007061919-A2 CONTACT LENSES WITH MUCIN AFFINITY BAUSCH & LOMB INCORPORATED (US) 2007-05-31 WO claimed
US-20070116740-A1 Contact lenses with mucin affinity BAUSCH & LOMB INCORPORATED 2007-05-24 US claimed
CN-120647981-A Sericin low-hysteresis composite conductive hydrogel and preparation method and application thereof 江南大学 2025-09-16 CN disclosed
US-20230212216-A1 SYNTHESIS OF LACTONE DERIVATIVES AND THEIR USE IN THE MODIFICATION OF PROTEINS GENIE BIOTECH UK LTD. (GB) 2023-07-06 US disclosed
US-20040248326-A1 Hydrogel compositions, devices, and microscale components REGENTS OF THE UNIVERSITY OF MINNESOTA 2004-12-09 US disclosed
WO-2003051286-A2 HYDROGEL COMPOSITIONS, DEVICES, AND MICROSCALE COMPONENTS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212216-A1 SYNTHESIS OF LACTONE DERIVATIVES AND THEIR USE IN THE MODIFICATION OF PROTEINS AGL, PGLS, DDOST ALDH1A1 3862/4885KDM4E 1126/4885TDP1 3872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.